BriaCell Therapeutics Corp. (BCTXW)
BCTXW Stock Price Chart
Explore BriaCell Therapeutics Corp. interactive price chart. Choose custom timeframes to analyze BCTXW price movements and trends.
BCTXW Company Profile
Discover essential business fundamentals and corporate details for BriaCell Therapeutics Corp. (BCTXW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
13 Aug 2012
Employees
16.00
Website
https://briacell.comCEO
William V. Williams FCPA,
Description
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
BCTXW Financial Timeline
Browse a chronological timeline of BriaCell Therapeutics Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 31 Oct 2023
EPS came in at $0.36 .
Earnings released on 30 Apr 2023
EPS came in at -$315.47 .
Earnings released on 31 Jan 2023
EPS came in at -$765.68 .
Earnings released on 31 Oct 2022
EPS came in at -$315.47 .
Earnings released on 31 Jul 2022
EPS came in at -$1.24K .
Earnings released on 31 Oct 2021
EPS came in at $58.47 .
Earnings released on 31 Jul 2021
EPS came in at $147.85 .
BCTXW Stock Performance
Access detailed BCTXW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.